Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
暂无分享,去创建一个
Y. Sasaki | H. Fujii | Y. Omuro | T. Watanabe | N. Katsumata | M. Ando | Y. Tokuda | M. Ohta | A. Okumura | T. Niwa | Masahiko Ando | Yutaka Tokuda | Takashi Watanabe | Tomoo Tajima